Actively Recruiting

Phase 2
Age: 18Years - 100Years
All Genders
NCT04791579

Antibiotic Prophylaxis for Neurogenic Bladder Botox

Led by University of Alberta · Updated on 2026-05-07

160

Participants Needed

1

Research Sites

134 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Injection of Botox into the bladder is a procedure used to treat neurogenic overactive bladder at the Dianne and Irving Kipnes Urology Centre in the Kaye Edmonton Clinic. A common complication following bladder Botox is bladder infection. There are no well-studied preventative antibiotics given at the time of bladder Botox for the reduction of post-operative bladder infection. We are proposing a research study that will randomize participants into two groups - one receiving antibiotics and the other receiving placebo pills following bladder Botox. The main goal of our study is to determine if preventative antibiotics at the time of bladder Botox injection reduces post-operative bladder infection. It will provide a valuable learning opportunity for a trainee starting their academic career through working closely with established researchers across two disciplines. We hope the results of our study can ultimately be used to improve outcomes and safety for a common Urologic procedure. In addition, findings from our study could help reduce unnecessary use of antibiotics resulting in cost savings in the health care system and reduction in the risk of antibiotic resistance.

CONDITIONS

Official Title

Antibiotic Prophylaxis for Neurogenic Bladder Botox

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants with neurogenic overactive bladder due to a neurologic condition such as multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, or similar
  • Age 18 years or older
  • Ability to read, speak, and write in English
  • No contraindications to Botox injection, including no hypersensitivity to botulinum toxin, no symptomatic urinary retention or post-void residual > 200 mL, and willingness to start clean intermittent catheterization if needed
  • No contraindications to oral ciprofloxacin, including no allergy to ciprofloxacin or other fluoroquinolones, and not taking Tizanidine or Agomelatine
  • Not currently on antibiotic therapy
  • Not pregnant or breastfeeding
  • No active symptomatic urinary tract infection on the day of the procedure
Not Eligible

You will not qualify if you...

  • Participants with idiopathic overactive bladder
  • Under 18 years of age
  • Unable to read, speak, or write in English
  • Contraindications to Botox injection, including hypersensitivity, symptomatic urinary retention or post-void residual > 200 mL, or unwillingness/inability to start clean intermittent catheterization if needed
  • Contraindications to oral ciprofloxacin, including allergy to ciprofloxacin or other fluoroquinolones, or taking Tizanidine or Agomelatine
  • Currently on antibiotic therapy
  • Pregnant or breastfeeding
  • Active symptomatic urinary tract infection on the day of the procedure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Alberta

Edmonton, Alberta, Canada, T6G2R3

Actively Recruiting

Loading map...

Research Team

J

Joseph LaBossiere, MD FRCSC

CONTACT

P

Paul Groves, MR FRCSC

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here